Connor, Clark & Lunn Investment Management Ltd. Cara Therapeutics, Inc. Call Options Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CARA
# of Institutions
19Shares Held
3.26MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY745KShares$3.87 Million0.0% of portfolio
-
National Asset Management, Inc. Boca Raton, FL58.5KShares$303,9810.0% of portfolio
-
American Portfolios Advisors Holbrook, NY40.4KShares$210,2100.02% of portfolio
-
Rathbones Group PLC Liverpool, X020.2KShares$104,8520.0% of portfolio
-
Rothschild Investment Corp10.6KShares$55,1200.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $279M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...